164 related articles for article (PubMed ID: 5020745)
1. Comparison of the inhibitory effects of lymphocytes from patients with and without cancer on the growth of human tumour cells in culture.
Jamieson CW
Br J Surg; 1972 Apr; 59(4):302. PubMed ID: 5020745
[No Abstract] [Full Text] [Related]
2. In vitro immunization to cultured human tumor cells.
Sharma B; Terasaki PI
Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
[No Abstract] [Full Text] [Related]
3. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
Bach ML; Bach FH; Zoschke DC
Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
[No Abstract] [Full Text] [Related]
4. Proceedings: Tumour immunity - cellular and humoral responses during tumour growth.
Baldwin RW; Embleton MJ; Price MR; Robins RA
Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139105
[No Abstract] [Full Text] [Related]
5. Workshop in human tumor immunology.
Oettgen HF; Bean MA; Klein G
Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
[No Abstract] [Full Text] [Related]
6. Problems in the use of in vitro assays for monitoring cell-mediated immunity in cancer patients.
de Vries JE
Bull Cancer; 1976; 63(2):279-86. PubMed ID: 791397
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
8. Proceedings: What is the clinical relevance of in-vitro tumour immunity test?
Moore M
Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139106
[No Abstract] [Full Text] [Related]
9. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
[No Abstract] [Full Text] [Related]
10. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
Sharma B; Koashi O; Mickey MR; Terasaki P
Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
[TBL] [Abstract][Full Text] [Related]
11. [Cellular immunity to tumor antigens].
Hellström KE; Hellström I
Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
[No Abstract] [Full Text] [Related]
12. Mixed organ culture as a tool for considering cellular tumor-host relationships in tumor patients.
Nissen E; Tanneberger S
Arch Geschwulstforsch; 1976; 46(4):281-93. PubMed ID: 971045
[TBL] [Abstract][Full Text] [Related]
13. Cellular immunity to human tumor-associated antigens. A review.
Herberman RB
Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
[No Abstract] [Full Text] [Related]
14. Cellular immunity and blocking antibodies to tumors.
Hellström I; Hellström KE
J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
[No Abstract] [Full Text] [Related]
15. In vitro studies of cell mediated immunity to human sarcomas.
Rella W; Kotz R; Vetterlein M
Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
[No Abstract] [Full Text] [Related]
16. [Letter: Cytotoxicity of lymphocytes in cancer patients. Influence of ionizing radiations].
Dubois JB; Serrou B; Pourquier H
Nouv Presse Med; 1975 Jan; 4(3):192-3. PubMed ID: 1129081
[No Abstract] [Full Text] [Related]
17. Role of soluble cytotoxins in cell-mediated immunity.
Walker SM; Lucas ZJ
Transplant Proc; 1973 Mar; 5(1):137-40. PubMed ID: 4572090
[No Abstract] [Full Text] [Related]
18. Depressed lymphocyte-mediated killing of sensitized targets in cancer patients.
Ting A; Terasaki PI
Cancer Res; 1974 Oct; 34(10):2694-8. PubMed ID: 4412732
[No Abstract] [Full Text] [Related]
19. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
20. Quantitation of the microassay for cell-mediated immunity through electronic image analysis.
Takasugi M; Mickey MR; Terasaki PI
Natl Cancer Inst Monogr; 1973 Jun; 37():77-84. PubMed ID: 4713786
[No Abstract] [Full Text] [Related]
[Next] [New Search]
